Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2008 Jul 1;5(7):e145.
doi: 10.1371/journal.pmed.0050145.

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Willem A Hanekom, Hazel M Dockrell, Tom H M Ottenhoff, T Mark Doherty, Helen Fletcher, Helen McShane, Frank F Weichold, Dan F Hoft, Shreemanta K Parida, Uli J Fruth
Guideline

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Willem A Hanekom et al. PLoS Med. .

Abstract

Willem Hanekom and colleagues make recommendations on assay harmonization for novel tuberculosis vaccine trials.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 2004;84:93–101. - PubMed
    1. Kaufmann SH, Baumann S, Nasser Eddine A. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis. Int J Tuberc Lung Dis. 2006;10:1068–1079. - PubMed
    1. Martin C. Tuberculosis vaccines: Past, present and future. Curr Opin Pulm Med. 2006;12:186–191. - PubMed
    1. Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol. 2006;4:469–476. - PubMed
    1. Lauvau G, Pamer EG. CD8 T cell detection of bacterial infection: Sniffing for formyl peptides derived from Mycobacterium tuberculosis. J Exp Med. 2001;193:F35–F39. - PMC - PubMed

Publication types

MeSH terms

Substances